Diazoxide: Pulmonary hypertension.

A study conducted between July 2017 and July 2022 reported on a patient who developed pulmonary hypertension while being treated with diazoxide for hyperinsulinaemic hypoglycaemia. The patient, whose age and sex were not provided, had been receiving diazoxide treatment for five years before developing pulmonary hypertension. Unfortunately, the patient died as a result of a pulmonary hypertensive crisis, despite receiving extracorporeal membrane oxygenation. [Extracted from the article]